| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 02/11/2003 | US6517841 Solid compositions and liquid preparations for oral administration which contain cocoa polyphenols |
| 02/11/2003 | US6517840 Production of a product enriched in isoflavone values from natural sources |
| 02/11/2003 | CA2047237C Chroman derivatives |
| 02/06/2003 | WO2003010116A2 Process for isolating phenolic compounds |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 02/06/2003 | WO2002048134A3 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 02/06/2003 | WO2002020506A3 SYNTHESIS OF 4α-ARYLEPICATECHINS |
| 02/06/2003 | US20030028019 Changes quickly into state of being colored in yellowish to reddish color tone upon irradiation with light containing ultraviolet rays such as of sunlight or light from mercury lamp, change being reversible; photochromic lenses |
| 02/06/2003 | US20030027862 Amino-and amido-diphenyl ethers |
| 02/06/2003 | US20030027857 Tocotrienol derivative, process for producing the same and gamma-CEHC delivering agent |
| 02/06/2003 | US20030027801 Administering substitued guanidine compounds for therapy of decreased blood flow or nutrient supply to retinal tissue or optic nerve, or retinal ischemia or trauma, or optic nerve injury |
| 02/06/2003 | US20030027798 For therapy |
| 02/06/2003 | US20030027238 Optical molecular sensors for cytochrome P450 activity |
| 02/06/2003 | CA2454636A1 Process for isolating phenolic compounds |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | EP1281712A1 Fluorescent pH indicators for intracellular assays |
| 02/05/2003 | EP1281710A1 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 02/05/2003 | EP1280789A1 Cdk inhibitors having 3-hydroxychromen-4-one structure |
| 02/05/2003 | EP1280757A2 New gamma selective retinoids |
| 02/05/2003 | CN1395574A Food product and producing method |
| 02/05/2003 | CN1395573A Extraction of flavonoids |
| 02/05/2003 | CN1394837A Method for producing chroman |
| 02/05/2003 | CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/05/2003 | CN1100759C Xanthene and arcridine derivative and its use |
| 02/04/2003 | US6514687 Screening a candidate compound for activity as a Cytochrome P450 enzyme substrate by contacting the compound, enzyme, and a reagent chromogen comprising the ether of a phenolic dye such as a coumarin, resofurin or fluorescein dye |
| 02/04/2003 | US6514633 Light emitting device material, light emitting device using thereof, and amine compound |
| 02/04/2003 | CA2178479C Chroman derivatives |
| 01/31/2003 | WO2002012169A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/31/2003 | CA2417880A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/30/2003 | WO2003008472A1 Photoactive materials |
| 01/30/2003 | WO2003007956A1 Treatment for attention-deficit hyperactivity disorder |
| 01/30/2003 | WO2003007927A1 Synthesis and functin inhibitors for heat shock proteins |
| 01/30/2003 | WO2002062333A9 Use of 9h-xanthenes in a method of inhibiting viral replication targeting the nucleocapsid protein |
| 01/30/2003 | WO2002013836A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient |
| 01/30/2003 | CA2417845A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient |
| 01/29/2003 | EP1278509A1 Lipochroman-6 as no-synthase inhibitor and uses |
| 01/29/2003 | EP1192145A4 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 01/29/2003 | EP1161434B1 Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 01/29/2003 | CN1393443A Process for preparing dihydromyricetin from porcelain ampelopsis |
| 01/29/2003 | CN1100055C Piperazine and piperidine compounds |
| 01/28/2003 | US6512005 Sodium, potassium and lithium warfarin salts; pharmacopeial grade purity |
| 01/28/2003 | US6512002 Methods of treatment for premature ejaculation in a male |
| 01/28/2003 | US6511988 Prevention binding of transcription factor tozinc finger binding compounds |
| 01/28/2003 | US6511977 For preventing or treating cardiac arrhythmia or atrial arrhythmia |
| 01/28/2003 | US6511966 Administering for therapy of mitochondria medited disease |
| 01/28/2003 | CA2078869C Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use |
| 01/23/2003 | WO2003006452A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006010A1 Aerosol formulations of δ8 tetrahydrocannabinol |
| 01/23/2003 | WO2003005960A2 Novel bicyclic and tricyclic cannabinoids |
| 01/23/2003 | WO2002098367A3 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453389A1 Aerosol formulations of .delta.8 tetrahydrocannabinol |
| 01/22/2003 | EP1277770A1 Photoactive materials |
| 01/22/2003 | EP1277760A1 Method of searching for arteriosclerosis inhibitors and shrinkers |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | EP1276734A1 Halogenated rhodamine derivatives and applications thereof |
| 01/22/2003 | EP1276730A2 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 01/22/2003 | EP1147100A4 Recovery of chroman derivatives |
| 01/22/2003 | EP1071660B1 N-sulphonyl and n-sulphinyl phenylglycinamide |
| 01/22/2003 | EP0729465B1 Pyrone derivatives as protease inhibitors and antiviral agents |
| 01/22/2003 | CN1392146A Water cress extract and its preparing method and use |
| 01/22/2003 | CN1392131A Process for purifying hypericin |
| 01/22/2003 | CN1392128A Process for preparing extract containing hypericin and flavon compounds |
| 01/22/2003 | CN1099286C Use of forskolin in manufacture of medicament for treatment of alcohol addiction |
| 01/21/2003 | US6509381 Phytochemical extracts enriched in at least two of the phytochemicals selected from the group consisting of isoflavones, lignans, saponins, catechins and phenolic acids; treatment of cancers and pre- and post-menstrual syndromes |
| 01/21/2003 | US6509372 Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin |
| 01/21/2003 | US6509362 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
| 01/21/2003 | CA2273099C Process for crystallizing d-alpha-tocopheryl succinate |
| 01/16/2003 | WO2003004569A1 Method for increasing hydrophilicity of fluorescent label compounds |
| 01/16/2003 | WO2003004486A2 Process for preparing isocoumarins |
| 01/16/2003 | WO2003004091A2 Aromatic sulfenates for type i phototherapy |
| 01/16/2003 | US20030013756 Hormone inhibitor; sexual disorders |
| 01/16/2003 | US20030013734 Skin disorders, immunology diseases, wound healing agents, antiulcer agents |
| 01/16/2003 | US20030013708 Therapeutic heterocyclic compounds |
| 01/16/2003 | US20030013705 Novel carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 01/16/2003 | US20030013702 Agents and methods for treatment of cancer |
| 01/16/2003 | US20030013677 Anticancer agents |
| 01/16/2003 | US20030013041 Write-once optical data carrier |
| 01/16/2003 | CA2452835A1 Aromatic sulfenates for type i phototherapy |
| 01/15/2003 | EP1275673A2 Epoxy resin composition, cured article thereof, novel epoxy resin, novel phenol compound, and process for preparing the same |
| 01/15/2003 | EP1274700A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 01/15/2003 | EP1274421A2 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses |
| 01/15/2003 | EP1274417A2 Treatment of movement disorders with metabotropic glutamate receptor antagonists |
| 01/15/2003 | EP1274408A2 Use of natural chrysanthone compounds having antiangiogenic activity |
| 01/15/2003 | EP1274404A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
| 01/15/2003 | EP1274319A2 Compositions and methods for improving vascular health |
| 01/15/2003 | EP0937057B1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 01/15/2003 | EP0787723B1 Cyclopropachromenecarboxylate derivatives |
| 01/15/2003 | CN1391568A Naphthopyrans annelated in C5-C6 with indene- or dihydronaphthalene-type and compositions and matrices containing them |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1098848C Acids and esters of diosmetin and pharmaceutical compositions containing them |
| 01/14/2003 | US6506912 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506796 Cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of |
| 01/14/2003 | US6506792 Breast and endometrial cancers are major causes of death in Western women. In particular, tumours in endocrine-dependent tissues, such as the breast and endometrium, occur most frequently in postmenopausal women at a time when the ovaries |
| 01/14/2003 | US6506538 Ophthalmic lenses, contact lenses, solar protection glasses, filters, camera optics or photographic apparatus optics or other optical devices |
| 01/14/2003 | US6506517 Surface modified carbonaceous materials |